Maestre-Muñiz Modesto M, Arias Ángel, Mata-Vázquez Emilia, Martín-Toledano María, López-Larramona Germán, Ruiz-Chicote Ana María, Nieto-Sandoval Bárbara, Lucendo Alfredo J
Department of Internal Medicine, Hospital General de Tomelloso, 13700 Ciudad Real, Spain.
Department of Medicine and Medical Specialties, Universidad de Alcalá, 28801 Alcalá de Henares, Spain.
J Clin Med. 2021 Jun 30;10(13):2945. doi: 10.3390/jcm10132945.
The long-term effects of COVID-19 remain largely unclear. This study aims to investigate post-acute health consequences and mortality one year after hospital discharge.
All surviving adult patients who were discharged after hospital admission due to acute COVID-19 in the first wave of the pandemic underwent a comprehensive interview. Functional assessment was performed in patients aged over 65. Clinical and hospital records were reviewed and mortality causes assessed.
A total of 587 patients with COVID-19 were discharged from hospital, including 266 after hospital admission and 321 from the emergency room. Mortality within the following year occurred in 34/266 (12.8%) and 10/321 (3.1%), respectively, due to causes directly or possibly related to COVID-19 in 20.5% and 25% of patients. Post-COVID-19 syndrome was assessed in 543 patients at one year from discharge. Any clinical complaint was reported by 90.1% of patients who needed hospitalization and 80.4% of those discharged from the emergency room ( = 0.002), with breathlessness (41.6%), tiredness (35.4%), ageusia (30.2%), and anosmia (26.3%) being the most common complaints. Ongoing symptoms attributed to COVID-19 were reported by 66.8% and 49.5% of patients, respectively ( < 0.001). Newly developed COPD, asthma, diabetes, heart failure, and arthritis-as well as worsening of preexisting comorbidities-were found.
One-year mortality among survivors of acute COVID-19 was 7.5%. A significant proportion of COVID-19 patients experienced ongoing symptoms at 1 year from onset of the disease.
新冠病毒病(COVID-19)的长期影响在很大程度上仍不清楚。本研究旨在调查出院后一年的急性后期健康后果和死亡率。
对在疫情第一波期间因急性COVID-19入院后出院的所有成年存活患者进行了全面访谈。对65岁以上的患者进行了功能评估。查阅了临床和医院记录并评估了死亡原因。
共有587例COVID-19患者出院,其中266例为入院后出院,321例从急诊室出院。在随后的一年中,死亡率分别为34/266(12.8%)和10/321(3.1%),因直接或可能与COVID-19相关的原因死亡的患者分别占20.5%和25%。在出院一年后对543例患者进行了COVID-19后综合征评估。需要住院治疗的患者中有90.1%以及从急诊室出院的患者中有80.4%报告了任何临床症状(P = 0.002),其中呼吸急促(41.6%)、疲劳(35.4%)、味觉减退(30.2%)和嗅觉丧失(26.3%)是最常见的症状。分别有66.8%和49.5%的患者报告了归因于COVID-19的持续症状(P < 0.001)。发现了新发生的慢性阻塞性肺疾病(COPD)、哮喘、糖尿病、心力衰竭和关节炎,以及原有合并症的恶化。
急性COVID-19幸存者的一年死亡率为7.5%。相当一部分COVID-19患者在疾病发作一年后仍有持续症状。